{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "USD", "marketState": "REGULAR", "exchange": "NMS", "shortName": "Zymeworks Inc.", "longName": "Zymeworks Inc.", "messageBoardId": "finmb_43279463", "exchangeTimezoneName": "America/New_York", "market": "us_market", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "esgPopulated": false, "regularMarketChangePercent": -7.0773897, "regularMarketPrice": 9.125, "firstTradeDateMilliseconds": 1493386200000, "regularMarketChange": -0.6949997, "regularMarketTime": 1684263290, "regularMarketDayHigh": 9.66, "regularMarketDayRange": "8.8301 - 9.66", "regularMarketDayLow": 8.8301, "regularMarketVolume": 495015, "regularMarketPreviousClose": 9.82, "bid": 9.17, "ask": 9.19, "bidSize": 18, "askSize": 8, "fullExchangeName": "NasdaqGS", "financialCurrency": "USD", "regularMarketOpen": 9.62, "averageDailyVolume3Month": 587536, "averageDailyVolume10Day": 511700, "fiftyTwoWeekLowChange": 5.015, "fiftyTwoWeekLowChangePercent": 1.2201946, "fiftyTwoWeekRange": "4.11 - 10.8", "fiftyTwoWeekHighChange": -1.6750002, "fiftyTwoWeekHighChangePercent": -0.15509261, "fiftyTwoWeekLow": 4.11, "fiftyTwoWeekHigh": 10.8, "earningsTimestamp": 1667943000, "earningsTimestampStart": 1690973940, "earningsTimestampEnd": 1691409600, "trailingAnnualDividendRate": 0.0, "trailingPE": 4.879679, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": 1.87, "epsForward": -1.45, "epsCurrentYear": -1.75, "priceEpsCurrentYear": -5.214286, "sharesOutstanding": 64171300, "bookValue": 7.389, "fiftyDayAverage": 8.9304, "fiftyDayAverageChange": 0.1946001, "fiftyDayAverageChangePercent": 0.021790748, "twoHundredDayAverage": 7.68285, "twoHundredDayAverageChange": 1.4421501, "twoHundredDayAverageChangePercent": 0.18771031, "marketCap": 585563136, "priceHint": 2, "forwardPE": -6.293103, "priceToBook": 1.2349439, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2022-12-16", "averageAnalystRating": "1.9 - Buy", "tradeable": false, "cryptoTradeable": false, "displayName": "Zymeworks", "symbol": "ZYME"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "114 East 4th Avenue", "address2": "Suite 800", "city": "Vancouver", "state": "BC", "zip": "V5T 1G4", "country": "Canada", "phone": "604-678-1388", "fax": "604-737-7077", "website": "https://www.zymeworks.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include Zanidatamab, a human epidermal growth factor receptor 2 (HER2) that is in Phase 1, Phase 2, and Phase 3 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas, breast, colorectal, and endometrial cancers; and zanidatamab zovodotin, a HER2 -targeted antibody-drug conjugate that is in Phase 1 clinical trial for the treatment of advanced or metastatic HER2-expressing tumors. It also develops a pipeline of preclinical product candidates and discovery-stage programs in oncology, including immuno-oncology agents and other therapeutic areas. The company has strategic partnerships and collaborations with BeiGene, Ltd.; Celgene Corporation; Celgene Alpine Investment Co. LLC; GlaxoSmithKline Intellectual Property Development Limited; Daiichi Sankyo Co., Ltd.; Janssen Biotech, Inc.; LEO Pharma A/S; Iconic Therapeutics, Inc.; Merck Sharp & Dohme Research GmbH; and Atreca, Inc. Zymeworks Inc. was incorporated in 2003 and is headquartered in Vancouver, Canada.", "fullTimeEmployees": 291, "companyOfficers": [{"maxAge": 1, "name": "Mr. Kenneth H. Galbraith C.A.", "age": 59, "title": "CEO & Chairman", "yearBorn": 1963, "fiscalYear": 2022, "totalPay": {"raw": 1224175, "fmt": "1.22M", "longFmt": "1,224,175"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Neil A. Klompas C.A., CPA, CA, CPA", "age": 50, "title": "Pres & COO", "yearBorn": 1972, "fiscalYear": 2022, "totalPay": {"raw": 858372, "fmt": "858.37k", "longFmt": "858,372"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 9872, "fmt": "9.87k", "longFmt": "9,872"}}, {"maxAge": 1, "name": "Dr. Christopher  Astle Ph.D.", "age": 42, "title": "Sr. VP & CFO", "yearBorn": 1980, "fiscalYear": 2022, "totalPay": {"raw": 721233, "fmt": "721.23k", "longFmt": "721,233"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Ali  Tehrani Ph.D.", "age": 50, "title": "Advisor", "yearBorn": 1972, "fiscalYear": 2022, "totalPay": {"raw": 964243, "fmt": "964.24k", "longFmt": "964,243"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Bijal  Desai M.B.A.", "title": "Exec. Director of Corp. Fin., FP&A & Procurement", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Mark  Hollywood", "age": 52, "title": "Exec. VP and Head of Technical & Manufacturing Operations", "yearBorn": 1970, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Paul  Moore Ph.D.", "age": 55, "title": "Chief Scientific Officer", "yearBorn": 1967, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Jack W. Spinks", "title": "Associate Director of Investor Relations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Daniel  Dex J.D., Ph.D.", "title": "Sr. VP, Corp. Sec. & Gen. Counsel", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Diana  Papove", "title": "Sr. Mang. of Corp. Communications", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}